ReShape Lifesciences has been granted a patent for an intragastric balloon system designed to treat obesity. The system includes a swallowable capsule containing a balloon with self-sealing and degradable valves for controlled deflation in the gastric environment. GlobalData’s report on ReShape Lifesciences gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on ReShape Lifesciences, Ostomy monitoring system was a key innovation area identified from patents. ReShape Lifesciences's grant share as of May 2024 was 37%. Grant share is based on the ratio of number of grants to total number of patents.
Intragastric balloon system for treating obesity
A recently granted patent (Publication Number: US11974934B2) discloses an innovative intragastric balloon system designed to aid in weight loss. The system comprises a swallowable capsule that degrades in the stomach, releasing a compacted balloon with separate fill and release valves. The release valve is designed to degrade in response to the presence of liquid in the balloon, allowing the liquid to escape into the stomach, deflating the balloon. This process is intended to occur between 1 to 6 months after the balloon is filled, facilitating its passage through the digestive tract and eventual excretion.
The system's release valve is engineered to degrade based on the internal environment of the balloon, triggered by factors such as pH, humidity, or the type of liquid used to fill the balloon, which can include saline or water. The design ensures that the balloon deflates at the appropriate time, aiding in its safe passage through the gastrointestinal tract. The patent also details variations in the construction of the release valve, including single or multiple layers and the use of erodible materials. Overall, the intragastric balloon system aims to provide a non-invasive and effective method for weight loss by utilizing innovative technology to safely deflate and eliminate the balloon post-treatment.
To know more about GlobalData’s detailed insights on ReShape Lifesciences, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
